Stereotactic body radiation therapy for sarcoma pulmonary metastases
Emily S. Lebow(University of Pennsylvania), Andreas Rimner(University Medical Center Freiburg), Narek Shaverdian(University of Wisconsin–Madison), Abraham J. Wu(Memorial Sloan Kettering Cancer Center), Kaled M. Alektiar(Memorial Sloan Kettering Cancer Center), William D. Tap(Memorial Sloan Kettering Cancer Center), Mark A. Dickson(Memorial Sloan Kettering Cancer Center), Stephanie Lobaugh(Memorial Sloan Kettering Cancer Center), Benjamin A. Nacev(University of Pittsburgh), Evan Rosenbaum(Memorial Sloan Kettering Cancer Center), Charles B. Simone(New York Proton Center), Suzanne L. Wolden(Memorial Sloan Kettering Cancer Center), Annemarie F. Shepherd(Memorial Sloan Kettering Cancer Center), Sandra P. D’Angelo(Memorial Sloan Kettering Cancer Center), Zhigang Zhang(Memorial Sloan Kettering Cancer Center), Daniel R. Gomez(Memorial Sloan Kettering Cancer Center), Daphna Y. Gelblum(Memorial Sloan Kettering Cancer Center)
Cited by 16
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
|Journal of Clinical Oncology|2015|1.1k
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|JAMA Oncology|2022|557